Submit Data |  Help |  Video Tutorials |  News |  Publications |  FTP Download |  REST API |  Citing RGD |  Contact   

Sirolimus induced phosphaturia is not caused by inhibition of renal apical sodium phosphate cotransporters.

Authors: Haller, M  Amatschek, S  Wilflingseder, J  Kainz, A  Bielesz, B  Pavik, I  Serra, A  Mohebbi, N  Biber, J  Wagner, CA  Oberbauer, R 
Citation: Haller M, etal., PLoS One. 2012;7(7):e39229. doi: 10.1371/journal.pone.0039229. Epub 2012 Jul 30.
Pubmed: (View Article at PubMed) PMID:22859939
DOI: Full-text: DOI:10.1371/journal.pone.0039229

The vast majority of glomerular filtrated phosphate is reabsorbed in the proximal tubule. Posttransplant phosphaturia is common and aggravated by sirolimus immunosuppression. The cause of sirolimus induced phosphaturia however remains elusive. Male Wistar rats received sirolimus or vehicle for 2 or 7 days (1.5mg/kg). The urine phosphate/creatinine ratio was higher and serum phosphate was lower in sirolimus treated rats, fractional excretion of phosphate was elevated and renal tubular phosphate reabsorption was reduced suggesting a renal cause for hypophosphatemia. PTH was lower in sirolimus treated rats. FGF 23 levels were unchanged at day 2 but lower in sirolimus treated rats after 7 days. Brush border membrane vesicle phosphate uptake was not altered in sirolimus treated groups or by direct incubation with sirolimus. mRNA, protein abundance, and subcellular transporter distribution of NaPi-IIa, Pit-2 and NHE3 were not different between groups but NaPi-IIc mRNA expression was lower at day 7. Transcriptome analyses revealed candidate genes that could be involved in the phosphaturic response. Sirolimus caused a selective renal phosphate leakage, which was not mediated by NaPi-IIa or NaPi-IIc regulation or localization. We hypothesize that another mechanism such as a basolateral phosphate transporter may be responsible for the sirolimus induced phosphaturia.


Disease Annotations
Objects Annotated

Additional Information

CRRD Object Information
CRRD ID: 8655928
Created: 2014-05-23
Species: All species
Last Modified: 2014-05-23
Status: ACTIVE


RGD is funded by grant HL64541 from the National Heart, Lung, and Blood Institute on behalf of the NIH.